Skip to main content
Log in

C-11-Methionin-PET/CT zur Lokalisation von Nebenschilddrüsenadenomen

Localization of parathyroid adenomas with C11-methionine PET-CT

  • Übersichten
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Die präoperative Lokalisationsdiagnostik von Nebenschilddrüsenadenomen beim primären Hyperparathyreoidismus (pHPT) ermöglicht eine fokussierte unilaterale Operation. Zur Standarddiagnostik zählen die Sonographie und Technetium-99m-Sestamibi-Szintigraphie. Das neueste Verfahren zur Darstellung hyperfunktioneller Nebenschilddrüsen stellt die C-11-Methionin-Positronenemissionstomographie/Computertomographie (PET/CT) dar.

Methodik

Es wurde eine selektive Literaturrecherche in PubMed mit den Stichworten „primary hyperparathyroidism and methionine“, „primary hyperparathyroidism and PET“, „parathyroid adenomas and methionine“ und „parathyroid adenomas and PET“ durchgeführt.

Ergebnisse

Mithilfe des Methionin PET/CT gelingt es in 79–91 % solitäre Nebenschilddrüsenadenome nachzuweisen. Vorteile des Verfahrens sind eine hohe Sensitivität auch bei Rezidiveingriffen oder gleichzeitig bestehenden Knotenstrumen sowie eine exakte anatomische Zuordnung auch von atypisch gelegenen Adenomen. Eine vollständige Darstellung einer Mehrdrüsenerkrankung gelingt dagegen nur selten. Als ungünstig zu bewerten sind derzeit noch die eingeschränkte Verfügbarkeit der Methode und die vergleichsweise hohen Kosten.

Schlussfolgerung

Durch das Methionin-PET/CT ist bei der Mehrzahl der untersuchten Patienten mit pHPT eine exakte Lokalisation solitärer Nebenschilddrüsenadenome möglich. Eine Indikation zur Durchführung besteht vor allem bei präoperativ negativer Standarddiagnostik und bei Rezidiveingriffen.

Abstract

Background and objectives

In primary hyperparathyroidism (pHPT) preoperative localization of parathyroid adenomas enables focussed unilateral parathyroidectomy. Ultrasound and sestamibi scintigraphy are the recommended standard procedures for primary diagnostics of pHPT and C-11 methionine positron emission tomography computed tomography (Met-PET/CT) is the latest technique for localization of hyperfunctioning parathyroid glands.

Methods

This review presents the results of Met-PET/CT on the basis of a selective literature search using the keywords “primary hyperparathyroidism and methionine”, “primary hyperparathyroidism and PET”, “parathyroid adenomas and methionine” and “parathyroid adenomas and PET”.

Results

Localization of single gland adenomas can be achieved with Met-PET/CT in 79–91 % of cases. The advantages of this procedure are a high sensitivity even in operations for recurrencies or concomitant thyroid nodules and an accurate detection even with atypical localizations. In multiglandular disease a localization of more than one hyperfunctioning gland remains difficult. Potential limitations of the method include the restricted availability and the relatively high costs of Met-PET/CT.

Conclusions

Using Met-PET/CT hyperfunctioning parathyroid glands can be exactly localized in most patients with pHPT. Indications for this procedure are mostly when preoperative standard tests are negative and in parathyroid surgery for recurrencies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. NIH conference (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 114:593–597

    Article  Google Scholar 

  2. Paik JM, Curhan GC, Taylor EN (2012) Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ (Epub ahead of print)

  3. Bilezikian JP, Khan AA, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement form the third international workshop. J Clin Endocrinol Metab 94:335–339

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Anderson JL, Vanwoerkom RC, Home BD et al (2011) Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 162(2):331–339

    Article  PubMed  Google Scholar 

  5. Bosworth C, Sachs MC, Duprez D et al (2013) Parathyroid hormone and arterial dysfunction in the Multi-Ethnic Study of Atherosclerosis. Clin Endocrinol (Epub ahead of print)

  6. Yu N, Leese GP, Donnan PT (2013) What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Epub ahead of print)

  7. Pasieka JL, Parsons LL, Demeure MJ et al (2002) Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26:942–949

    Article  PubMed  Google Scholar 

  8. Roman SA, Sosa JA, Pietrzak RH et al (2011) The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg 253:131–137

    Article  PubMed  Google Scholar 

  9. Weber T, Eberle J, Messelhäuser U et al (2013) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism. JAMA Surg 148:109–115

    Article  PubMed  Google Scholar 

  10. Tibblin S, Bondeson AG, Ljungberg O (1982) Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 195(3):245–252

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Harari A, Allendorf J, Shifrin A et al (2009) Negative preoperative localization leads to greater resource use in the era of minimally invasive parathyroidectomy. Am J Surg 197(6):767–773

    Article  Google Scholar 

  12. Bergenfelz AO, Hellman P, Harrison B et al (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394(5):761–764

    Article  PubMed  Google Scholar 

  13. Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery (SQRTPAS), Annual Report 2012: www.http://81.216.105.171/assets/Annual-Report-2012.pdf

  14. Prommegger R, Wimmer G, Profanter C et al (2009) Virtual neck exploration. A new method for localizing abnormal parathyroid glands. Ann Surg 250:761–765

    Article  PubMed  Google Scholar 

  15. Dy BM, Richards ML, Vasquez BJ et al (2012) Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 19:2272–2278

    Article  PubMed  Google Scholar 

  16. Bergenfelz AO, Wallin G, Jansson S et al (2011) Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Langenbecks Arch Surg 396:83–90

    Article  PubMed  Google Scholar 

  17. Cheung K, Wang TS, Farrokhyar F et al (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19:577–583

    Article  PubMed  Google Scholar 

  18. Madorin CA, Owen R, Coakley B et al (2013) Comparison of radiation exposure and cost between dynamic computed tomography and sestamibi scintigraphy for preoperative localization of parathyroid lesions. JAMA Surg (epub ahead of print)

  19. Grayev AM, Gentry LR, Hartman MJ et al (2012) Presurgical localization of parathyroid adenomas with magnetic resonance imaging at 3.0 T: an adjunct method to supplement traditional imaging. Ann Surg Oncol 19:981–989

    Article  PubMed  Google Scholar 

  20. Reidel MA, Schilling T, Graf S et al (2006) Localization of hyperfunctioning parathyroid glands by selective venous sampling in reoperation for primary or secondary hyperparathyroidism. Surgery 140:907–913

    Article  PubMed  Google Scholar 

  21. Hellman P, Ahlströ, H, Bergström M et al (1994) Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery 116:974–981

    CAS  PubMed  Google Scholar 

  22. Hessman O, Stalberg P, Sundin A et al (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781

    Article  PubMed  Google Scholar 

  23. Tang B-N-T, Moreno-Reyes R, Blocklet D et al (2008) Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging 3:157–163

    Article  CAS  PubMed  Google Scholar 

  24. Öksüz MÖ, Dittmann H, Wicke C et al (2011) Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia. Diagn Interv Radiol 17:297–307

    PubMed  Google Scholar 

  25. Schmidt MC, Kahraman D, Neumaier B et al (2011) Tc-99m-MIBI-negative parathyroid adenoma in primary hyperparathyroidism detected by C-11-Methionine PET/CT after previous thyroid surgery. Clin Nucl Med 36:1153–1155

    Article  PubMed  Google Scholar 

  26. Weber T, Maier-Funk C, Ohlhauser D et al (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:1124–1128

    Article  PubMed  Google Scholar 

  27. Schalin-Jäntti C, Ryhänen E, Heiskanen I et al (2013) Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med 54:739–747

    Article  PubMed  Google Scholar 

  28. Arnalsteen L, Quievreux JL, Huglo D et al (2004) Reoperation for persistent or recurrent primary hyperparathyroidism. Seventy-seven cases among 1888 operated patients. Ann Chir 129:224–231

    Article  CAS  PubMed  Google Scholar 

  29. Karakas E, Müller HH, Schlosshauer T et al (2013) Reoperations for primary hyperparathyroidism – improvement of outcome over two decades. Langenbecks Arch Surg 398:99–106

    Article  PubMed  Google Scholar 

  30. Maier-Funk C, Weber T, Lang G et al (2010) Intrathoracic metastatic spread of parathyroid carcinoma. Nuklearmedizin 49:N62

    CAS  PubMed  Google Scholar 

  31. Weber T, Cammerer G, Schick C et al (2010) C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. Horm Metab Res 42:209–214

    Article  CAS  PubMed  Google Scholar 

Download references

Danksagung

Die Autoren danken allen Mitarbeitern und Kollegen der Kliniken für Allgemein- und Viszeralchirurgie und Nuklearmedizin des Universitätsklinikums Ulm, die sich mit der klinischen Anwendung des Met-PET/CT beim primären Hyperparathyreoidismus beschäftigt haben. Besonderer Dank gilt Herrn Dr. Clemens Maier-Funk, Frau Dagmar Ohlhauser, Herrn Dr. Martin Gottstein und Frau Dr. Janet Bampoe Addo für ihr großes Engagement bei der Durchführung und Auswertung der PET/CT-Aufnahmen.

Einhaltung ethischer Richtlinien

Interessenkonflikt. T. Weber erhielt Vortragshonorare der Firma Genzyme GmbH und ein Forschungsstipendium der B. Braun-Stiftung. M. Luster erhielt Vortragshonorare der Firmen Genzyme GmbH, Bayer HealthCare AG, Sanofi Aventis, Merck und AstraZeneca. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Weber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weber, T., Luster, M. C-11-Methionin-PET/CT zur Lokalisation von Nebenschilddrüsenadenomen. Chirurg 85, 601–606 (2014). https://doi.org/10.1007/s00104-013-2695-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-013-2695-5

Schlüsselwörter

Keywords

Navigation